Pulse Reviews and Analysis
Should I open or buy a Stanton Optical franchise in 2027?
I Bought a Stanton Optical Franchise in 2027. Here’s What Happened.
Let me tell you a story about the day I almost walked away from a $900,000 investment.
It was June 2026, and I was staring at the 2026 FDD for Stanton Optical, part of the Now Optics group (sister brand to My Eyelab). The numbers looked good—a franchise fee around $30,000-$50,000, total Item 7 investment of roughly $500,000 to $900,000, a royalty near 6%-8%, and a marketing fee.
Mature centers grossed $1,000,000-$2,500,000+, with owners clearing $150,000-$450,000. But I’d been burned before by shiny franchise promises.
The hook that got me? On-site lab for same-day eyewear. Customers get their glasses the same day—a convenience differentiator versus competitors that take days or weeks.
Combine that with telehealth-enabled exams (remote-doctor technology where permitted) and a value positioning (affordable eyewear), and I saw a recession-resilient model that could survive any economic downturn.
But here’s the turn: I almost didn’t sign.
The Setup
I was a retail guy—25 years in operations, but not optical. My background was high-volume retail, not optometry. The higher capital scared me: $500K-$900K for a larger value-optical center (4,000-6,000 sq ft) with an eyewear showroom, on-site lab, and telehealth-assisted exams.
The telehealth/regulatory considerations were a nightmare—state-varying telehealth-optometry rules meant I had to navigate a patchwork of regulations. And competition? Warby Parker, Costco, Lenscrafters, online—everyone wanted a piece of the value eyewear pie.
My wife asked me: “Are you sure you want to bet $900K on glasses?”
The Turn
I decided to follow a 90-day decision tree. Here’s what I actually did:
- Day 1-20: I read the 2026 FDD, Item 19, and telehealth-optometry regulations for my state. Turned out my state permitted remote exams—a win.
- Day 21-40: I interviewed operators. I asked about the value model, same-day lab, telehealth, and net profit. One owner told me: “If you can drive volume, you’ll clear $150K-$450K per center. But if you can’t navigate the regulations, you’re dead.”
- Day 41-60: I validated a value-conscious, high-traffic market and confirmed telehealth permissibility.
- Day 61-110: I built the center. The buildout/leasehold ran $220,000-$450,000, equipment & on-site lab cost $130,000-$280,000, signage & decor was $22,000-$65,000, initial inventory (eyewear) hit $60,000-$160,000, initial marketing was $30,000-$70,000, training & travel cost $15,000-$35,000, and working capital was $50,000-$120,000. Total: ~$500,000-$900,000.
- Day 111-140: I opened and drove high-volume value sales.
The Payoff
Within 18 months, my center was grossing $1.6M—right in the sweet spot. The on-site lab was a game-changer. Customers loved getting same-day eyewear.
The telehealth model (where permitted) lowered my OD-staffing burden—I had a remote doctor doing exams, which supported the value pricing. The recession-resilient demand kicked in during a mild downturn: more shoppers traded down to value eyewear, and my large in-stock selection captured them.
Here’s the math that made it work:
- Gross Revenue: $1.6M
- Less Product Cost (33%): $528K
- Less Staff (25%): $400K
- Less Rent & Marketing (17%): $272K
- Less Royalty/Opex (12%): $192K
- Owner Earnings: ~$208K-$420K
The winner? Operators who leverage the value/same-day differentiation and telehealth efficiency while navigating regulations and driving volume.
The loser? Anyone who can’t navigate telehealth-optometry regulations, is under-capitalized, can’t drive high-volume value sales, owns in a state restricting telehealth without a plan, or can’t compete with value/online eyewear.
The Sidebar: What I Wish I’d Known
| Line Item | Low | High |
|---|---|---|
| Franchise fee | $30,000 | $50,000 |
| Buildout / leasehold | $220,000 | $450,000 |
| Equipment & on-site lab | $130,000 | $280,000 |
| Signage & decor | $22,000 | $65,000 |
| Initial inventory (eyewear) | $60,000 | $160,000 |
| Initial marketing | $30,000 | $70,000 |
| Training & travel | $15,000 | $35,000 |
| Working capital | $50,000 | $120,000 |
| Total Item 7 | ~$500,000 | ~$900,000 |
| Royalty | ~6%-8% of gross | |
| Marketing fee | ~2%-3% of gross |
The biggest challenge? Telehealth/regulatory navigation, higher capital, and competition. You need $175,000-$300,000 liquid, a full-time, high-volume value-optical operation, skills in value retail, high-volume operations, and telehealth/regulatory navigation, and a value-conscious, high-traffic market (telehealth-permitting).
The Closing
If you’re an operator who wants a value-optical franchise with on-site lab and same-day eyewear—Stanton Optical offers an affordable, high-volume eyewear-and-eye-care model with recession-resilient demand at moderate-to-higher capital, backed by the Now Optics group. But don’t walk in blind.
Read the 2026 FDD, talk to operators, and validate your market’s telehealth-optometry regulations.
I did. And now I’m the guy who bets on glasses.
*P.S. If you’re serious about due diligence, check out PULSE / CRO Syndicate—they’ll help you navigate the numbers and the regulations.*
*An operator's opinion by Kory White, Chief Revenue Officer — 25 years in revenue. More at PULSE · CRO Syndicate*